Offstream
news

COVID-19 pandemic

The European Medicines Agency announces that blood clotting should be listed as a "very rare" side effect of the Oxford–AstraZeneca vaccine. It also insists that benefits of using the vaccine continue to outweigh the risks.

Sources:  DW